HighTower Advisors
IOVA icon

HighTower Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

HighTower Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60K Buy
+14,435
New +$54.8K ﹤0.01% 3712
2026
Q1 		– Sell
-19,089
Closed -$52.1K – 3878
2025
Q4 		$52.1K Buy
19,089
+7,718
+68% +$17.9K ﹤0.01% 3575
2025
Q3 		$24.7K Sell
11,371
-177,507
-94% -$419K ﹤0.01% 3659
2025
Q2 		$325K Buy
188,878
+111,312
+144% +$277K ﹤0.01% 2861
2025
Q1 		$258K Sell
77,566
-1,672
-2% -$8.62K ﹤0.01% 2984
2024
Q4 		$586K Buy
79,238
+2,951
+4% +$27.4K ﹤0.01% 2352
2024
Q3 		$716K Buy
76,287
+84
+0.1% +$796 ﹤0.01% 2138
2024
Q2 		$611K Buy
+76,203
New +$817K ﹤0.01% 2174
2022
Q3 		– Sell
-12,050
Closed -$132K – 3266
2022
Q2 		$132K Buy
12,050
+769
+7% +$10.1K ﹤0.01% 2723
2022
Q1 		$189K Buy
11,281
+845
+8% +$13.1K ﹤0.01% 2857
2021
Q4 		$198K Sell
10,436
-658
-6% -$14.5K ﹤0.01% 2784
2021
Q3 		$275K Sell
11,094
-3,093
-22% -$72.9K ﹤0.01% 2475
2021
Q2 		$368K Buy
+14,187
New +$369K ﹤0.01% 2235
2020
Q2 		– Sell
-7,535
Closed -$227K – 2481
2020
Q1 		$227K Buy
+7,535
New +$200K ﹤0.01% 1722
2019
Q3 		– Sell
-13,103
Closed -$308K – 2472
2019
Q2 		$308K Buy
+13,103
New +$197K ﹤0.01% 1789

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

HighTower Advisors's IOVA Position: Q2 2026 in Review

HighTower Advisors opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 14,435 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #3712 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in IOVA as recently as Q4 2025.

HighTower Advisors first reported a position in IOVA in Q2 2019 and has held it in 15 quarters since. The position peaked at $716K in Q3 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • HighTower Advisors held 14,435 shares of Iovance Biotherapeutics worth $60K as of Q2 2026.
  • Iovance Biotherapeutics was a new HighTower Advisors position in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3712 holding.
  • HighTower Advisors first reported a position in Iovance Biotherapeutics in Q2 2019 and has held it in 15 quarters since.
  • HighTower Advisors's Iovance Biotherapeutics position peaked at $716K in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.